A Protocol of Irinotecan for Carcinoma of the Lung

NCT01654081 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Slow accrual

Conditions

Lung Cancer

Interventions

DRUG: Irinotecan

Sponsor

Susanne Arnold